[YWHAE-rearranged clear cell sarcoma of kidney: a clinicopathological analysis of seven cases].

PubMed 2026

View at publisher
Authors: Z W Xing, X L Wang, L Chen
DOI: 10.3760/cma.j.cn112151-20251027-00710
Cited by: 0

Abstract

YWHAE-rearranged CCSK exhibits morphological heterogeneity and aggressive behaviors. Definitive diagnosis relies on molecular testing (such as FISH or NGS), which is crucial for differential diagnosis and prognostic evaluation. This subtype of CCSK is commonly associated with advanced clinical stage and early metastasis/recurrence, highlighting the necessity for improving risk stratification and clinical management.

Fields of Study & Subjects

Sarcoma Diagnosis and Treatment Renal cell carcinoma treatment Chromatin Remodeling and Cancer

Publication details

Journal / source
PubMed
Volume
55
Issue
2
Pages
140–146
Publication date
8 February 2026
Language
ZH